Truncated Leaflet For Prosthetic Heart Valves

Patent No. EP3266416 (titled "Truncated Leaflet For Prosthetic Heart Valves") was filed by Edwards Lifesciences on Dec 16, 2013. The application was issued on Mar 20, 2024.

Patent Summary

A prosthetic heart valve with improved performance and durability, comprising a leaflet frame and synthetic leaflets with a unique truncated base design. The leaflets are coupled to the frame and feature a planar central zone, diverging sides, and a free edge. The truncated base design enables a larger alpha angle while maintaining a short valve length, providing better leaflet bending behavior and improved hemodynamic performance. The valve is suitable for surgical and transcatheter placement, and can be delivered via a percutaneous transcatheter system.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
EDWARDS LIFESCIENCESSep 12, 2019SOMERVILLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3266416

EDWARDS LIFESCIENCES
Application Number
EP17187595A
Filing Date
Dec 16, 2013
Status
Patent Maintained As Amended
Feb 16, 2024
Publication Date
Mar 20, 2024